Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC25697930;7931;7932 chr2:178773259;178773258;178773257chr2:179637986;179637985;179637984
N2AB25697930;7931;7932 chr2:178773259;178773258;178773257chr2:179637986;179637985;179637984
N2A25697930;7931;7932 chr2:178773259;178773258;178773257chr2:179637986;179637985;179637984
N2B25237792;7793;7794 chr2:178773259;178773258;178773257chr2:179637986;179637985;179637984
Novex-125237792;7793;7794 chr2:178773259;178773258;178773257chr2:179637986;179637985;179637984
Novex-225237792;7793;7794 chr2:178773259;178773258;178773257chr2:179637986;179637985;179637984
Novex-325697930;7931;7932 chr2:178773259;178773258;178773257chr2:179637986;179637985;179637984

Information

  • RefSeq wild type amino acid: D
  • RefSeq wild type transcript codon: GAC
  • RefSeq wild type template codon: CTG
  • Domain: Ig-15
  • Domain position: 37
  • Structural Position: 52
  • Q(SASA): 0.7354
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
D/E rs2091797689 None 0.027 N 0.251 0.1 0.16115917748 gnomAD-4.0.0 1.59094E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85688E-06 0 0
D/V None None 0.484 N 0.415 0.202 0.239305524855 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
D/A 0.2004 likely_benign 0.2093 benign -0.25 Destabilizing 0.027 N 0.296 neutral N 0.453349168 None None N
D/C 0.5186 ambiguous 0.5313 ambiguous 0.011 Stabilizing 0.935 D 0.373 neutral None None None None N
D/E 0.1276 likely_benign 0.135 benign -0.232 Destabilizing 0.027 N 0.251 neutral N 0.447021404 None None N
D/F 0.6213 likely_pathogenic 0.6333 pathogenic -0.222 Destabilizing 0.791 D 0.374 neutral None None None None N
D/G 0.0757 likely_benign 0.0765 benign -0.451 Destabilizing None N 0.154 neutral N 0.312349747 None None N
D/H 0.2274 likely_benign 0.2376 benign -0.134 Destabilizing 0.317 N 0.329 neutral N 0.45352837 None None N
D/I 0.495 ambiguous 0.5047 ambiguous 0.231 Stabilizing 0.555 D 0.391 neutral None None None None N
D/K 0.2671 likely_benign 0.2794 benign 0.153 Stabilizing 0.001 N 0.217 neutral None None None None N
D/L 0.418 ambiguous 0.4269 ambiguous 0.231 Stabilizing 0.38 N 0.422 neutral None None None None N
D/M 0.584 likely_pathogenic 0.606 pathogenic 0.366 Stabilizing 0.935 D 0.365 neutral None None None None N
D/N 0.074 likely_benign 0.0757 benign -0.023 Destabilizing None N 0.148 neutral N 0.397277626 None None N
D/P 0.864 likely_pathogenic 0.857 pathogenic 0.093 Stabilizing 0.555 D 0.357 neutral None None None None N
D/Q 0.2396 likely_benign 0.2552 benign 0.014 Stabilizing 0.38 N 0.295 neutral None None None None N
D/R 0.3145 likely_benign 0.3249 benign 0.318 Stabilizing 0.081 N 0.367 neutral None None None None N
D/S 0.1145 likely_benign 0.1172 benign -0.175 Destabilizing 0.035 N 0.223 neutral None None None None N
D/T 0.2694 likely_benign 0.2704 benign -0.025 Destabilizing 0.149 N 0.28 neutral None None None None N
D/V 0.324 likely_benign 0.3274 benign 0.093 Stabilizing 0.484 N 0.415 neutral N 0.454893956 None None N
D/W 0.7944 likely_pathogenic 0.8128 pathogenic -0.124 Destabilizing 0.935 D 0.475 neutral None None None None N
D/Y 0.2159 likely_benign 0.2185 benign -0.005 Destabilizing 0.741 D 0.373 neutral N 0.453766363 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.